Nursing Asthm A Case Study
Asthma effects over 2 million Americans and presents in various forms depending on the individual’s number of events (Woo & Wynne, 2011). Classification of the frequency of one’s symptoms and use of medications indicate the level of control one has of their asthma. S.E.’s documented history of “mild persistent” asthma and presentation of symptoms requiring the use an albuterol inhaler daily, in addition to hospitalization twice in a year and frequent emergency department visits (ED) identify asthma which is not well controlled. Managing asthma focuses on both reducing the impairment of an individual related to symptoms and reducing the risk associated with the progression of decline of one’s respiratory function (National Asthma Education
…show more content…
in regards to pregnancy requires consistent prenatal monitoring and well controlled symptoms to ensure acceptable oxygenation for both mother and fetus (Woo & Wynne, 2011). S.E. will be monitored for lung function by her primary care provider and at all prenatal visits as recommended (NAEPP, 2007). S.E.’s treatment will require her to maintain the use of her albuterol inhaler for short acting rescue uses as it is recommended as the safest beta agonist to use in pregnancy (NAEPP, 2007). The new medications will include, discontinuing her fluticasone MDI and replacing it with budesonide inhaled dose of 180 mcg twice daily which is the recommended in pregnancy (NAEPP, 207). S.E. will be started on the lowest dose given that she was not nonadherent to the prescribed regimen of twice daily use of fluticasone. S.E. will require monitoring every 2-6 weeks but preferably every 2 weeks until her asthma is well controlled. The budesonide dosing may be titrated up as needed for effective asthma control. S.E. will be provided education regarding the daily use of the inhaled corticosteroid and the importance of properly following the prescribed regimen. If improvement is not seen at the follow up evaluation, S.E. will be transitioned to a combination medication. The medication of choice during pregnancy is Symbicort the combination of budesonide and formoterol (Rance & O’Laughlen, 2013). In addition, she will be made aware of the importance of seeking
in regards to pregnancy requires consistent prenatal monitoring and well controlled symptoms to ensure acceptable oxygenation for both mother and fetus (Woo & Wynne, 2011). S.E. will be monitored for lung function by her primary care provider and at all prenatal visits as recommended (NAEPP, 2007). S.E.’s treatment will require her to maintain the use of her albuterol inhaler for short acting rescue uses as it is recommended as the safest beta agonist to use in pregnancy (NAEPP, 2007). The new medications will include, discontinuing her fluticasone MDI and replacing it with budesonide inhaled dose of 180 mcg twice daily which is the recommended in pregnancy (NAEPP, 207). S.E. will be started on the lowest dose given that she was not nonadherent to the prescribed regimen of twice daily use of fluticasone. S.E. will require monitoring every 2-6 weeks but preferably every 2 weeks until her asthma is well controlled. The budesonide dosing may be titrated up as needed for effective asthma control. S.E. will be provided education regarding the daily use of the inhaled corticosteroid and the importance of properly following the prescribed regimen. If improvement is not seen at the follow up evaluation, S.E. will be transitioned to a combination medication. The medication of choice during pregnancy is Symbicort the combination of budesonide and formoterol (Rance & O’Laughlen, 2013). In addition, she will be made aware of the importance of seeking